News and Press Releases
9/12/2017 Press Release
AJHP's September 15 Theme Issue Focuses on Population HealthThe September 15, 2017, “Population Health” theme issue of AJHP (American Journal of Health-System Pharmacy) explores the pharmacist’s role in improving the outcomes of individuals with some of today’s most prevalent health problems, such as diabetes, hypertension, opioid misuse and abuse, hepatitis
Proposed 340B-Related Changes to Outpatient PPS Are Shortsighted, ASHP SaysCutting the reimbursement rate for drugs bought through the federal 340B Drug Pricing Program for Medicare beneficiaries will “curtail patient access to services, increase costs, [and] reduce hospitals’ flexibility to allocate their resources,” ASHP told the Centers for Medicare & Medicaid Services (CMS) on Monday.
9/8/2017 Press Release
ASHP Reaches Out to Members Impacted by Hurricane IrmaIn a communication sent this week to ASHP members who may be impacted by Hurricane Irma, ASHP CEO Paul Abramowitz commended practitioners who will give of their time, resources and expertise to meet the needs of patients and healthcare organizations during the storm. “In the past several weeks, ter
Kingwood Pharmacy Team Meets Harvey's ChallengesAs she reflected on her hospital’s recent encounter with Hurricane Harvey, Mallory Gessner-Wharton, director of pharmacy at Kingwood Medical Center in Texas, was pleased with the outstanding efforts of her dedicated staff.
9/5/2017 Press Release
ASHP Survey Finds Nearly All U.S. Hospitals Use EHRs, CPOE SystemsTechnologies that improve medication use have been adopted by nearly 100% of hospitals across the United States, according to the “ASHP National Survey of Pharmacy Practice in Hospital Settings: Prescribing and Transcribing — 2016.” Implementation of technologies such as electronic health records (E
Houston Methodist Hospital's Pharmacy Team Weathers the Storm"We never had an issue of people not wanting to come to work or not wanting to help out," said Alex C. Varkey on Friday, during a 15-minute break from directing pharmacy services at 907-bed Houston Methodist Hospital. "It's just been an incredible experience to see how strong a team we have here."
First Gene-Transfer Therapy Approved for U.S. MarketFDA on August 30 announced the approval of tisagenlecleucel, a first-in-class chimeric antigen receptor (CAR) T-cell immunotherapy consisting of genetically modified autologous T cells, for the treatment of B-cell precursor acute lymphoblastic leukemia (ALL) in children and young adults.
8/28/2017 Press Release